This inventor holds 1 USPTO granted patent. Top assignee: Hafslund Nycomed A/s. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Tellef Fossli: Innovator in Medical Treatments
Introduction
Tellef Fossli is a notable inventor based in Nissedal, Norway. He has made significant contributions to the field of medical treatments, particularly in addressing lesions in the large intestinal epithelium. His innovative approach has the potential to impact many lives.
Latest Patents
Fossli holds a patent for a method aimed at treating hyperproliferative benign or malignant lesions in the large intestinal epithelium. The method involves administering the tripeptide L-pyroglutamyl-L-histidyl-glycine, which is designed to provide effective treatment options for patients suffering from these conditions. This patent showcases his commitment to advancing medical science.
Career Highlights
Throughout his career, Tellef Fossli has worked with Hafslund Nycomed A/S, a company known for its focus on healthcare and pharmaceuticals. His work there has allowed him to develop and refine his innovative methods, contributing to the company's mission of improving patient outcomes.
Collaborations
Fossli has collaborated with esteemed colleagues such as Karl Ludwig Reichelt and Oyvind Skraastad. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing the impact of his work.
Conclusion
Tellef Fossli's contributions to medical treatments through his patented methods highlight his role as an influential inventor in the healthcare sector. His dedication to improving patient care is evident in his innovative approaches and collaborations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile